Skip to contentS
SeaStar Medical Holding Corp
S
ICUCWSeaStar Medical Holding Corp Q1 2024 · 10-Q
Revenue$0.00$0.00no prior Q1 2023 on file Net Income-$12.70M-$12.70MN/M vs Q1 2023 EPS Diluted-$4.73-$4.73N/M vs Q1 2023 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
SeaStar Medical Holding Corp · CIK 1831868 · Engraved from SEC EDGAR
Operating Cash Flow-$3,488,000N/M ended Mar 31, 2024 · filed May 14, 2024 · 44 d after period end